163 related articles for article (PubMed ID: 36092957)
21. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: A single-center retrospective analysis of 3273 cases.
Liu W; Cheng R; Su Y; Diao C; Qian J; Zhang J; Ma Y; Fan Y
Medicine (Baltimore); 2017 Oct; 96(43):e8365. PubMed ID: 29069024
[TBL] [Abstract][Full Text] [Related]
22. Expression and significance of TSGF, CEA and AFP in patients before and after radical surgery for colon cancer.
Hu Y; Wang JL; Tao HT; Wu BS; Sun J; Cheng Y; Dong WW; Li RX
Asian Pac J Cancer Prev; 2013; 14(6):3877-80. PubMed ID: 23886200
[TBL] [Abstract][Full Text] [Related]
23. Risk Factors for and Prediction Model of Skip Metastasis to Lateral Lymph Nodes in Papillary Thyroid Carcinoma.
Hu D; Lin H; Zeng X; Wang T; Deng J; Su X
World J Surg; 2020 May; 44(5):1498-1505. PubMed ID: 31863139
[TBL] [Abstract][Full Text] [Related]
24. Cytomorphological factors and BRAF mutation predicting risk of lymph node metastasis in preoperative liquid-based fine needle aspirations of papillary thyroid carcinoma.
Chung SY; Lee JS; Lee H; Park SH; Kim SJ; Ryu HS
Acta Cytol; 2013; 57(3):252-8. PubMed ID: 23636013
[TBL] [Abstract][Full Text] [Related]
25. Experience and analysis of Delphian lymph node metastasis in patients with papillary thyroid carcinoma.
Kim WW; Yang SI; Kim JH; Choi YS; Park YH; Kwon SK
World J Surg Oncol; 2012 Oct; 10():226. PubMed ID: 23110552
[TBL] [Abstract][Full Text] [Related]
26. An Evaluation of Clinicopathological Factors Effective in the Development of Central and Lateral Lymph Node Metastasis in Papillary Thyroid Cancer.
Aydin Buyruk B; Kebapci N; Yorulmaz G; Buyruk A; Kebapci M
J Natl Med Assoc; 2018 Aug; 110(4):384-390. PubMed ID: 30126565
[TBL] [Abstract][Full Text] [Related]
27. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma].
Sun L; Wang DM; Zhang WJ; Zhang J; Wu JF
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):123-126. PubMed ID: 29871201
[No Abstract] [Full Text] [Related]
28. The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma.
Liu Y; Lv H; Zhang S; Shi B; Sun Y
Front Endocrinol (Lausanne); 2021; 12():772071. PubMed ID: 34867817
[TBL] [Abstract][Full Text] [Related]
29. A Novel Scoring System for Predicting the Metastases of Posterior Right Recurrent Laryngeal Nerve Lymph Node Involvement in Patients With Papillary Thyroid Carcinoma by Preoperative Ultrasound.
Lu KN; Zhang Y; Da JY; Zhou TH; Zhao LQ; Peng Y; Pan G; Shi JJ; Zhou L; Ni YQ; Luo DC
Front Endocrinol (Lausanne); 2021; 12():738138. PubMed ID: 34531829
[TBL] [Abstract][Full Text] [Related]
30. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
Jiang XL; Zhang H; Chen YL; Peng L
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
[No Abstract] [Full Text] [Related]
31. [Risk factors analyses for lateral neck lymph node metastasis in papillary thyroid carcinoma].
Qi ZJ; Liu LF; Cheng L; Han X; Wang T; Li F; Lu C; Zhang AB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):603-606. PubMed ID: 31327195
[No Abstract] [Full Text] [Related]
32. [Predictors of level V lymphatic metastasis in papillary thyroid carcinoma].
Chen R; Wei T; Li ZH; Gong RX; Zhu JQ
Zhonghua Wai Ke Za Zhi; 2012 Jul; 50(7):625-8. PubMed ID: 22943994
[TBL] [Abstract][Full Text] [Related]
33. [Clinicopathological factors in risk prediction of lymph node metastasis in papillary thyroid carcinoma].
Yue C; Zhang Y; Xing L; Zhao Y; Chen J; Jin Y; Liu H
Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(46):3637-41. PubMed ID: 25622954
[TBL] [Abstract][Full Text] [Related]
34. Risk Factors for Neck Nodal Metastasis in Papillary Thyroid Cancer With BRAF V600E Mutation.
Han Y; Hou L; Zhao B; Gao L; Li S
Front Endocrinol (Lausanne); 2022; 13():884428. PubMed ID: 35784548
[TBL] [Abstract][Full Text] [Related]
35. NONHSAT076754 aids ultrasonography in predicting lymph node metastasis and promotes migration and invasion of papillary thyroid cancer cells.
Xia S; Wang C; Ni X; Ni Z; Dong Y; Zhan W
Oncotarget; 2017 Jan; 8(2):2293-2306. PubMed ID: 27906682
[TBL] [Abstract][Full Text] [Related]
36. Preoperatively Predicting the Central Lymph Node Metastasis for Papillary Thyroid Cancer Patients With Hashimoto's Thyroiditis.
Min Y; Huang Y; Wei M; Wei X; Chen H; Wang X; Chen J; Xiang K; Feng Y; Yin G
Front Endocrinol (Lausanne); 2021; 12():713475. PubMed ID: 34367075
[TBL] [Abstract][Full Text] [Related]
37. Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma, in the Central and Lateral Compartments, in Children and Adolescents: Predictive Factors.
Spinelli C; Tognetti F; Strambi S; Morganti R; Massimino M; Collini P
World J Surg; 2018 Aug; 42(8):2444-2453. PubMed ID: 29383423
[TBL] [Abstract][Full Text] [Related]
38. Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus.
Oka M; Hazama S; Takahashi M; Yamamoto K; Abe T; Yoshino S; Hayashi H; Tangoku A
Hepatogastroenterology; 1999; 46(28):2254-9. PubMed ID: 10521976
[TBL] [Abstract][Full Text] [Related]
39. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis.
Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B
Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894
[TBL] [Abstract][Full Text] [Related]
40. Serum TSH levels are associated with postoperative recurrence and lymph node metastasis of papillary thyroid carcinoma.
Xiang Y; Xu Y; Bhandari A; Sindan N; Hirachan S; Yang Q; Guo G; Shen Y
Am J Transl Res; 2021; 13(6):6108-6116. PubMed ID: 34306349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]